Presentation
Title of abstract: O-T10-06 Evaluation of radiological biomarkers in breast cancer patients using the contrast- enhanced spectral mammography method
Synopsis: Site of origin of cancers can be determined by analysing the mammographic tumor features the so-called imaging biomarkers. Currently MG examination can be performed with a new method - by intravenous administration of a iodine-containing contrast agent. The aim of the research is, by studying radiological biomarkers of breast cancer patients with the new contrast-enhanced spectral mammography (CESM) method, to establish in which biomarkers this method is useful for additional examination.
This agenda item is presented in the following session: S8-4 Breast Radiology
Plenary session
08.10.2022 15:30 - 17:00